PATTERN BIOSCIENCES
Pattern BioSciences is an early stage biotechnology start-up company and an ETH Zurich spin-off. The company develops programmable cancer gene therapies using gene circuit technologies.
PATTERN BIOSCIENCES
Industry:
Biotechnology Genetics Health Care Therapeutics
Founded:
2018-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.patternbio.com
Total Employee:
1+
Status:
Active
Contact:
+41-61-387-3339
Email Addresses:
[email protected]
Total Funding:
71.43 K EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Content Delivery Network Euro GStatic Google Static Content Wix Wix Bookings Softlayer
Similar Organizations
AC-Gen Reading Life
AC-Gen Reading Life is a pioneer company in Spain in the application of technology Next Generation Sequencing (NGS) of DNA.
Calimmune
Calimmune is a clinical-stage gene therapy company.
CroBio
CroBio is an agricultural biotechnology start-up specializing in synthetic biology.
Plantik Biosciences
Plantik Biosciences develops new plant breeding technology to create future plants faster.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Pattern BioSciences
Newest Events participated
Official Site Inspections
http://www.patternbio.com
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Pattern BioSciences"
Pattern Biosciences
We build DNA computers to cure disease. These DNA computers sense and respond to multiple molecular cues at a single cell level, identify complex molecular patterns of disease with โฆSee details»
Home - Pattern Bioscience
Single-cell microbiology decodes metabolic patterns of individual bacterial cells, bypassing time-consuming culture steps.See details»
Pattern BioSciences - Crunchbase Company Profile & Funding
Pattern BioSciences is an early-stage biotechnology start up company and an ETH Zurich spin-off.See details»
Pattern BioSciences Company Profile 2024: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Pattern BioSciences. Use the PitchBook Platform to explore the full profile.See details»
About Us - Pattern Bioscience
We advance single-cell microbiology to make targeted antimicrobial treatment information available days sooner. With our strong patent portfolio, Pattern is positioned to revolutionize โฆSee details»
Pattern Biosciences Management Team | Org Chart - RocketReach
VP Translational R and D and Co-founder at Pattern Biosciences Basel, BS, CH View 2 ethz.ch patternbio.comSee details»
Pattern Bioscience - LinkedIn
Pattern Bioscience | 3,978 followers on LinkedIn. Our mission is simple: We will improve the world's most important health decisions. | Tackling a global health threat like antimicrobial ...See details»
Pattern BioSciences GmbH - VentureRadar
Develops programmable therapies utilizing gene circuit technologies, originating as an ETH Zurich spin-off biotechnology start-up company. "Next Generation Programmable Therapies Pattern โฆSee details»
Pattern Biosciences - Products, Competitors, Financials, Employees ...
Pattern Biosciences focuses on developing biomolecular computing technology to create therapies for diseases such as cancer. Use the CB Insights Platform to explore Pattern โฆSee details»
Pattern Biosciences - Contact
681 Gateway Boulevard South San Francisco, CA 94080Let's talkSee details»
Pattern BioSciences - Overview, News & Competitors
View Pattern BioSciences (www.patternbio.com) location in Basel-City, Switzerland , revenue, industry and description. Find related and similar companies as well as employees by title and โฆSee details»
Pattern BioSciences AG - startup
Pattern BioSciences AG: Pattern BioSciences is an early stage biotechnology start up company and an ETH Zurich spin-off. The company develops programmable cancer gene therapies โฆSee details»
Pattern Raises Additional $9M to Fast-track New Technology for โฆ
Jul 14, 2020 Led by Illumina Ventures, the Series B-1 round will accelerate development and validation of transformational bacterial testing technology AUSTIN, Texas, July 14, 2020 โ โฆSee details»
Pattern Biosciences - Careers
With U.S. headquarters in South San Francisco, we are building a world-class team with a shared mission to reprogram disease for health.See details»
Pattern BioSciences AG โ Swiss Biotech
We are BioLizard, a global leader in data science solutions for the life sciences industry. Our passion is to bridge the gap between the biological and computational spheres, empowering โฆSee details»
Pattern Secures $13M in Development Funding
Feb 4, 2020 $6.8M CARB-X award plus $6.4M Series B led by Omnimed will help bring new technology to the fight against drug resistance. AUSTIN, Texas, February 4, 2020 โ Pattern โฆSee details»
Scientist or Senior Scientist, In Vivo Pharmacology - patternbio.com
About the Role Are you passionate about working with cutting-edge technologies to develop next generation therapies? You will advance the early pipeline of innovative cancer therapies โฆSee details»
Scientist or Senior Scientist, Synthetic Biology - patternbio.com
South San Francisco Scientist/Senior Scientist, Synthetic Biology Pattern Biosciences South San Francisco, CA www.patternbio.com โ About the Company Do you want to be at the forefront of โฆSee details»
Pattern Receives FDA โBreakthrough Device Designationโ for โฆ
AUSTIN, Texas, December 8, 2021 โ Pattern Bioscience, Inc. has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Pneumonia โฆSee details»
Our Science - Pattern Bioscience
The result? A steady stream of antibiotic overuse and the rising tide of drug resistance. Without faster diagnostics that clinicians can trust, routine surgeries and medical treatments could โฆSee details»